ArticleTherapeutic advances in medical oncology2026

Pegylated liposomal doxorubicin plus carboplatin versus paclitaxel plus carboplatin as first-line therapy for epithelial ovarian cancer (CGCS-04): a multicenter, randomized clinical trial.

Yuanming Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.